Deprescribing Benzodiazepines in Older Patients: Impact of Interventions Targeting Physicians, Pharmacists, and Patients

被引:77
|
作者
Ng, Brendan J. [1 ,2 ,3 ,4 ]
Le Couteur, David G. [1 ,4 ]
Hilmer, Sarah N. [1 ,2 ,3 ]
机构
[1] Univ Sydney, Fac Med, Sydney, NSW, Australia
[2] Royal North Shore Hosp, Kolling Inst, Dept Aged Care, St Leonards, NSW, Australia
[3] Royal North Shore Hosp, Kolling Inst, Dept Clin Pharmacol, St Leonards, NSW, Australia
[4] Concord Hosp, Ageing & Alzheimers Inst, Concord, NSW, Australia
关键词
COGNITIVE-BEHAVIORAL THERAPY; RANDOMIZED CONTROLLED-TRIAL; LONG-TERM USERS; AGED; 65; YEARS; INAPPROPRIATE BENZODIAZEPINE; GENERAL-PRACTICE; NURSING-HOMES; DOUBLE-BLIND; Z-DRUGS; HOSPITAL INPATIENTS;
D O I
10.1007/s40266-018-0544-4
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Benzodiazepines (BZDs; including the related Z-drugs) are frequently targets for deprescribing; long-term use in older people is harmful and often not beneficial. BZDs can result in significant harms, including falls, fractures, cognitive impairment, car crashes and a significant financial and legal burden to society. Deprescribing BZDs is problematic due to a complex interaction of drug, patient, physician and systematic barriers, including concern about a potentially distressing but rarely fatal withdrawal syndrome. Multiple studies have trialled interventions to deprescribe BZDs in older people and are discussed in this narrative review. Reported success rates of deprescribing BZD interventions range between 27 and 80%, and this variability can be attributed to heterogeneity of methodological approaches and limited generalisability to cognitively impaired patients. Interventions targeting the patient and/or carer include raising awareness (direct-to-consumer education, minimal interventions, and 'one-off' geriatrician counselling) and resourcing the patient (gradual dose reduction [GDR] with or without cognitive behavioural therapy, teaching relaxation techniques, and sleep hygiene). These are effective if the patient is motivated to cease and is not significantly cognitively impaired. Interventions targeted to physicians include prescribing interventions by audit, algorithm or medication review, and providing supervised GDR in combination with medication substitution. Pharmacists have less frequently been the targets for studies, but have key roles in several multifaceted interventions. Interventions are evaluated according to the Behaviour Change Wheel. Research supports trialling a stepwise approach in the cognitively intact older person, but having a low threshold to use less-consultative methods in patients with dementia. Several resources are available to support deprescribing of BZDs in clinical practice, including online protocols.
引用
收藏
页码:493 / 521
页数:29
相关论文
共 50 条
  • [31] Effectiveness of Interventions to Reduce Potentially Inappropriate Medication in Older Patients: A Systematic Review
    Rodrigues, Daniela A.
    Placido, Ana I.
    Mateos-Campos, Ramona
    Figueiras, Adolfo
    Herdeiro, Maria Teresa
    Roque, Fatima
    FRONTIERS IN PHARMACOLOGY, 2022, 12
  • [32] Impact of coaching by community pharmacists on drug attitude of depressive primary care patients and acceptability to patients; a randomized controlled trial
    Brook, O
    van Hout, H
    Nieuwenhuyse, H
    Heerdink, E
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2003, 13 (01) : 1 - 9
  • [33] Interventions for involving older patients with multi-morbidity in decision-making during primary care consultations
    Butterworth, Joanne E.
    Hays, Rebecca
    McDonagh, Sinead T. J.
    Richards, Suzanne H.
    Bower, Peter
    Campbell, John
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2019, (10):
  • [34] Prevalence and impact of polypharmacy in older patients with type 2 diabetes
    Remelli, Francesca
    Ceresini, Maria Giorgia
    Trevisan, Caterina
    Noale, Marianna
    Volpato, Stefano
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2022, 34 (09) : 1969 - 1983
  • [35] Impact of Substance Use on Older Patients With Human Immunodeficiency Virus
    Muhrer, Jill
    JNP-JOURNAL FOR NURSE PRACTITIONERS, 2019, 15 (10): : 772 - 776
  • [36] Prevalence and impact of polypharmacy in older patients with type 2 diabetes
    Francesca Remelli
    Maria Giorgia Ceresini
    Caterina Trevisan
    Marianna Noale
    Stefano Volpato
    Aging Clinical and Experimental Research, 2022, 34 : 1969 - 1983
  • [37] Psychological interventions targeting patients with metastatic cancer and prolonged survival expectancies: advances and challenges
    Righes, Sadio
    Lewis, Florence
    Waroquier, Pauline
    Delevallez, France
    Merckaert, Isabelle
    CURRENT OPINION IN ONCOLOGY, 2022, 34 (04) : 256 - 264
  • [38] Impact of Biologic Agents With and Without Concomitant Methotrexate and at Reduced Doses in Older Rheumatoid Arthritis Patients
    Zhang, Jie
    Xie, Fenglong
    Delzell, Elizabeth
    Yun, Huifeng
    Lewis, James D.
    Haynes, Kevin
    Chen, Lang
    Beukelman, Timothy
    Saag, Kenneth G.
    Curtis, Jeffrey R.
    ARTHRITIS CARE & RESEARCH, 2015, 67 (05) : 624 - 632
  • [39] eHealth-Based Interventions for Older Patients with Prostate Cancer: A Quick Review of the Literature
    Silva Neto, Luiz Sinesio
    Ferreira Dias, Fellipe Camargo
    Osorio, Neila Barbosa
    Artioli Rolim, Carmem Lucia
    TELEMEDICINE REPORTS, 2022, 3 (01): : 79 - 92
  • [40] Tumor biology in older breast cancer patients - What is the impact on survival stratified for guideline adherence? A retrospective multicentre cohort study of 5378 patients
    Ebner, Florian
    van Ewijk, Reyn
    Woeckel, Achim
    Hancke, Katharina
    Schwentner, Lukas
    Fink, Visnja
    Kreienberg, Rolf
    Janni, Wolfgang
    Blettner, Maria
    BREAST, 2015, 24 (03): : 256 - 262